Introduction
Antimicrobial resistance is not new, but the number of resistant organisms, the geographic locations affected by drug resistance, and the breadth of resistance in single organisms are unprecedented and mounting. Diseases and disease agents that were once thought to be controlled by antibiotics are returning in new leagues resistant to these therapies. [1] Antibiotics are used both in treating human disease and in intensive farming to promote animal growth. Both uses may be contributing to the rapid development of antibiotic resistance in bacterial populations. [2] Thus by acquiring the genes which make bacteria resistant to various antibiotics include MRSA (methicillin resistant Staphylococcus aureus) was first detected in Britain in 1961 and is now quite common. The first documented strain with complete (>16 ug/ml) resistance to vancomycin, termed VRSA (vancomycin resistant Staphylococcus aureus) appeared in the United States in 2002. [3] Ethylene diamine tetra acetic acid (EDTA) is a polyamino carboxylic acid and a colourless, water soluble solid. EDTA is used to bind metal ions in the alternative medical practice of chelation therapy. EDTA have various uses in different fields such as medical, chemical and veterinary; its water solubility and low toxicity made it more friendly so it can use in combination with antibiotics to increase the potency of antibiotics, as well as against the multidrug resistant microorganisms. [4] Farca et al., (1997) studied synergistic effects of the combination of EDTA-tromethamine (EDTA-tris) and three antimicrobial agents (cephaloridine, kanendomycin and enrofloxacin) against resistant Gram positive and Gram negative bacteria. Animals exposed to EDTA tromethamine plus the antibiotics recovered completely within 10 days and were controlled clinically and bacteriologically for 180 days. [5] EDTA-antibiotic combination to control Pseudomonas aeruginosa was done by Mohamed et al., (2006) in which six multidrug resistant strains from patients at Tanta University hospital, Egypt were tested against the the antibiotics with or without the EDTA. It was found out that 70% of the strains turned from resistant to sensitive. [6] The main objective of the present study was to screen pathogenic Staphylococcus aureus and to study their sensitivity, resistance pattern with special relevance to analyze the effect of EDTA in combination with selected antibiotics.
II.
Material And Methods:
Collection of Clinical Samples:
Skin swab samples were collected from different pathology laboratories of Nagpur, India from March 2010 to July 2010. This was indeed collected from the patients not responding to routine antibiotic therapy. A total of 102 organisms were isolated from 50 skin swab samples. These isolated bacterial cultures were transferred to microbiology laboratory for further processing.
Identification of Isolated Pathogens:
The isolated bacterial pathogens were identified on the basis of morphological, cultural and biochemical characteristics and results were compared with Bergey's Manual of Determinative Bacteriology 9 th edition. [7] From 102 isolates, 70 were confirmed as Staphylococcus aureus.
Preparation of Inoculum:
A loopful culture of each Staphylococcus aureus was inoculated in 5ml of sterile nutrient broth tube. The inoculated broth was incubated for 8 hours at 37 0 C and the turbidity was measured using 0.5 McFarland standards.
Antibiotic Sensitivity Test:
All the Staphylococcus aureus were subsequently tested for antibiotic sensitivity patterns by disc diffusion method on Mueller Hinton Agar. [8] The three different antibiotic discs such as Teicoplanin (30 mcg), Vancomycin (30 mcg) and Methicillin (5 mcg) were obtained from Hi-Media Laboratories Pvt. Ltd. Mumbai. The results were interpretated as per Clinical and Laboratory Standards Institute (CLSI) guidelines.
[9]
Selection of Antibiotic Resistant Staphylococcus aureus:
Out of 70 Staphylococcus aureus strains tested against 3 selected antibiotics, 5 strains not showed zone of inhibition and were considered as antibiotic resistant Staphylococcus aureus. These 5 strains were selected for further study with EDTA.
Selection of EDTA Concentrations:
The preliminary experiments were carried out by using eight different concentrations of EDTA such as 1.95mM, 3.9mM, 7.8mM, 15.6mM, 31.2mM, 62.5mM, 125mM and 250mM. The 250mM concentration of the EDTA solution inhibited the bacterial growth therefore the concentration of EDTA used for further study was 250mM.
[10]
Potentiating Effect of EDTA:
For the study of potentiating effect of EDTA against Staphylococcus aureus strains, the antibiotic discs were applied on the Mueller Hinton agar plate lawned with Staphylococcus aureus culture. A 10 ul of EDTA solution was pippeted onto the each antibiotic disc of the plates. [11] After incubation at 37 0 C for 24 hours the strains were observed for the formation of zone of inhibition against the tested antibiotics with EDTA.
III. Results:
The antibiotic susceptibility test by the disc diffusion method of 70 Staphylococcus aureus was performed against teicoplanin, vancomycin and methicillin. Out of these 70 Staphylococcus aureus isolates only 5 isolates were found to be multidrug resistant. The preliminary experiments were carried out by using eight different concentrations of EDTA such as 1.95mM, 3.9mM, 7.8mM, 15.6mM, 31.2mM, 62.5mM, 125mM and 250mM. The 250mM concentration of the EDTA solution inhibited the bacterial growth therefore the concentration of EDTA used for further study was 250mM (Table 1) . Also potentiating activity of EDTA was checked with all antibiotics, it was found that EDTA potentiated activities of teicoplanin, vancomycin and methicillin (Table 2) .
IV.
Discussion:
Multi drug resistant Staphylococcus aureus isolate no. 11 showed resistance against teicoplanin, vancomycin, and methicillin. It became sensitive to teicoplanin (10 mm) and methicillin (12 mm) when treated with EDTA, but did not show sensitivity against vancomycin. Multi drug resistant Staphylococcus aureus isolate no. 43 showed resistance against teicoplanin, vancomycin and methicillin. It became sensitive to teicoplanin (11 mm) and methicillin (13 mm) when treated with EDTA (11mm,13mm), but did not show sensitivity against vancomycin. Multi drug resistant Staphylococcus aureus isolate no. 60 showed resistance against teicoplanin, vancomycin and methicillin. It became sensitive to methicillin when treated with EDTA (13mm), but did not show sensitivity against teicoplanin and vancomycin. Multi drug resistant Staphylococcus aureus isolate no. 69 showed resistance against teicoplanin, vancomycin and methicillin. It became sensitive to vancomycin (11 mm) and methicillin (13 mm) when treated with EDTA, but did not show sensitivity against teicoplanin. Multi drug resistant Staphylococcus aureus isolate no. 64 showed resistance against methicillin whereas sensitive to teicoplanin (15 mm) and vancomycin (15mm). The sensitivity of multi drug resistant Staphylococcus aureus isolate was found to be increased against teicoplanin (16 mm) and vancomycin (16 mm) when treated with EDTA than that of the previous, but did not show sensitivity against methicillin ( Table 2) . The results were correlated with that of Farca et al., 1994; 1997 in the context of the potentiating effect of EDTA on these antibiotic resistant Staphylococcus aureus.
[5] [12] Overall, the result reported in this study showed that the combination of antibiotic plus EDTA increases the sensitivity of multi drug resistant Staphylococcus aureus against the selected antibiotics to which previously the organism was resistant. The present study may be fruitful to overcome the problems raised from multi drug resistant pathogens. 125mM  250mM  11  NZ  NZ  NZ  NZ  <10  <10  10  13  43  NZ  NZ  NZ  NZ  NZ  10  12  15  60  NZ  NZ  NZ  NZ  <10  <10  10  10  64  NZ  NZ  NZ  NZ  <10  10  11  15  69  NZ  NZ  NZ  NZ  <10  <10  <10  16 Where, MDR SA= Multi Drug Resistant Staphylococcus aureus, NZ= No Zone of inhibition 
